Anti-Inflammatory Biologics Market Size, Share & COVID-19 Impact Analysis, By Drug Class (Anti-Tumor Necrosis Factor (TNF), Interleukin Antagonists, Janus Kinase (JAK) Inhibitors, and Others), By Application (Rheumatoid Arthritis, Psoriasis, and Others), By Route of Administration (Oral and Injection (Subcutaneous and Intravenous)), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and Regional Forecast, 2026-2034

Last Updated: March 16, 2026 | Format: PDF | Report ID: FBI102733

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Prevalence of Rheumatoid Arthritis & Psoriasis – For Key Countries
2. Pipeline Analysis
3. Patent Snapshot
4. New Product Launches
5. Key Industry Developments - Mergers, Acquisitions and Partnerships
Global Anti-inflammatory Biologics Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Drug Class
  1. Anti-Tumor Necrosis Factor (TNF)
  2. Interleukin Antagonists
  3. Janus Kinase (JAK) Inhibitors
  4. Others
2. Market Analysis, Insights and Forecast – By Application
  1. Rheumatoid Arthritis
  2. Psoriasis
  3. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Injection
    1. Subcutaneous
    2. Intravenous
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacy
  2. Retail Pharmacy
  3. Online Pharmacy
5. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Anti-inflammatory Biologics Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Drug Class
  1. Anti-Tumor Necrosis Factor (TNF)
  2. Interleukin Antagonists
  3. Janus Kinase (JAK) Inhibitors
  4. Others
2. Market Analysis, Insights and Forecast – By Application
  1. Rheumatoid Arthritis
  2. Psoriasis
  3. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Injection
    1. Subcutaneous
    2. Intravenous
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacy
  2. Retail Pharmacy
  3. Online Pharmacy
5. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Anti-inflammatory Biologics Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Drug Class
  1. Anti-Tumor Necrosis Factor (TNF)
  2. Interleukin Antagonists
  3. Janus Kinase (JAK) Inhibitors
  4. Others
2. Market Analysis, Insights and Forecast – By Application
  1. Rheumatoid Arthritis
  2. Psoriasis
  3. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Injection
    1. Subcutaneous
    2. Intravenous
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacy
  2. Retail Pharmacy
  3. Online Pharmacy
5. Market Analysis, Insights and Forecast – By Countries/ Sub-region
  1. U.K.
  2. Germany
  3. France
  4. Spain
  5. Italy
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Anti-inflammatory Biologics Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Drug Class
  1. Anti-Tumor Necrosis Factor (TNF)
  2. Interleukin Antagonists
  3. Janus Kinase (JAK) Inhibitors
  4. Others
2. Market Analysis, Insights and Forecast – By Application
  1. Rheumatoid Arthritis
  2. Psoriasis
  3. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Injection
    1. Subcutaneous
    2. Intravenous
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacy
  2. Retail Pharmacy
  3. Online Pharmacy
5. Market Analysis, Insights and Forecast – By Countries/ Sub-region
  1. Japan
  2. China
  3. India
  4. Australia
  5. Southeast Asia
  6. Rest of Asia Pacific
Latin America Anti-inflammatory Biologics Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Drug Class
  1. Anti-Tumor Necrosis Factor (TNF)
  2. Interleukin Antagonists
  3. Janus Kinase (JAK) Inhibitors
  4. Others
2. Market Analysis, Insights and Forecast – By Application
  1. Rheumatoid Arthritis
  2. Psoriasis
  3. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Injection
    1. Subcutaneous
    2. Intravenous
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacy
  2. Retail Pharmacy
  3. Online Pharmacy
5. Market Analysis, Insights and Forecast – By Countries/ Sub regions
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Anti-inflammatory Biologics Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Drug Class
  1. Anti-Tumor Necrosis Factor (TNF)
  2. Interleukin Antagonists
  3. Janus Kinase (JAK) Inhibitors
  4. Others
2. Market Analysis, Insights and Forecast – By Application
  1. Rheumatoid Arthritis
  2. Psoriasis
  3. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Injection
    1. Subcutaneous
    2. Intravenous
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacy
  2. Retail Pharmacy
  3. Online Pharmacy
5. Market Analysis, Insights and Forecast – By Countries/ Sub region
  1. South Africa
  2. GCC
  3. Rest of Middle East & Africa
Competitive Analysis
1. Global Market Share Analysis (2021)
2. Company Profiles
  1. AbbVie Inc.
    1. Overview
    2. Products
    3. SWOT analysis
    4. Recent developments
    5. strategies
    6. financials (based on availability)
  2. Johnson & Johnson Services, Inc.
    1. Overview
    2. Products
    3. SWOT analysis
    4. Recent developments
    5. strategies
    6. financials (based on availability)
  3. Bristol-Myers Squibb Company
    1. Overview
    2. Products
    3. SWOT analysis
    4. Recent developments
    5. strategies
    6. financials (based on availability)
  4. Merck & Co., Inc.
    1. Overview
    2. Products
    3. SWOT analysis
    4. Recent developments
    5. strategies
    6. financials (based on availability)
  5. Pfizer Inc.
    1. Overview
    2. Products
    3. SWOT analysis
    4. Recent developments
    5. strategies
    6. financials (based on availability)
  6. Novartis AG
    1. Overview
    2. Products
    3. SWOT analysis
    4. Recent developments
    5. strategies
    6. financials (based on availability)
  7. UCB S.A.
    1. Overview
    2. Products
    3. SWOT analysis
    4. Recent developments
    5. strategies
    6. financials (based on availability)
  8. Eli Lilly and Company
    1. Overview
    2. Products
    3. SWOT analysis
    4. Recent developments
    5. strategies
    6. financials (based on availability)
  9. Amgen Inc.
    1. Overview
    2. Products
    3. SWOT analysis
    4. Recent developments
    5. strategies
    6. financials (based on availability)
  10. Biogen
    1. Overview
    2. Products
    3. SWOT analysis
    4. Recent developments
    5. strategies
    6. financials (based on availability)

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Prevalence of Rheumatoid Arthritis & Psoriasis – For Key Countries
2. Pipeline Analysis
3. Patent Snapshot
4. New Product Launches
5. Key Industry Developments - Mergers, Acquisitions and Partnerships
Global Anti-inflammatory Biologics Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Drug Class
  1. Anti-Tumor Necrosis Factor (TNF)
  2. Interleukin Antagonists
  3. Janus Kinase (JAK) Inhibitors
  4. Others
2. Market Analysis, Insights and Forecast – By Application
  1. Rheumatoid Arthritis
  2. Psoriasis
  3. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Injection
    1. Subcutaneous
    2. Intravenous
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacy
  2. Retail Pharmacy
  3. Online Pharmacy
5. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Anti-inflammatory Biologics Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Drug Class
  1. Anti-Tumor Necrosis Factor (TNF)
  2. Interleukin Antagonists
  3. Janus Kinase (JAK) Inhibitors
  4. Others
2. Market Analysis, Insights and Forecast – By Application
  1. Rheumatoid Arthritis
  2. Psoriasis
  3. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Injection
    1. Subcutaneous
    2. Intravenous
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacy
  2. Retail Pharmacy
  3. Online Pharmacy
5. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Anti-inflammatory Biologics Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Drug Class
  1. Anti-Tumor Necrosis Factor (TNF)
  2. Interleukin Antagonists
  3. Janus Kinase (JAK) Inhibitors
  4. Others
2. Market Analysis, Insights and Forecast – By Application
  1. Rheumatoid Arthritis
  2. Psoriasis
  3. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Injection
    1. Subcutaneous
    2. Intravenous
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacy
  2. Retail Pharmacy
  3. Online Pharmacy
5. Market Analysis, Insights and Forecast – By Countries/ Sub-region
  1. U.K.
  2. Germany
  3. France
  4. Spain
  5. Italy
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Anti-inflammatory Biologics Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Drug Class
  1. Anti-Tumor Necrosis Factor (TNF)
  2. Interleukin Antagonists
  3. Janus Kinase (JAK) Inhibitors
  4. Others
2. Market Analysis, Insights and Forecast – By Application
  1. Rheumatoid Arthritis
  2. Psoriasis
  3. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Injection
    1. Subcutaneous
    2. Intravenous
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacy
  2. Retail Pharmacy
  3. Online Pharmacy
5. Market Analysis, Insights and Forecast – By Countries/ Sub-region
  1. Japan
  2. China
  3. India
  4. Australia
  5. Southeast Asia
  6. Rest of Asia Pacific
Latin America Anti-inflammatory Biologics Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Drug Class
  1. Anti-Tumor Necrosis Factor (TNF)
  2. Interleukin Antagonists
  3. Janus Kinase (JAK) Inhibitors
  4. Others
2. Market Analysis, Insights and Forecast – By Application
  1. Rheumatoid Arthritis
  2. Psoriasis
  3. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Injection
    1. Subcutaneous
    2. Intravenous
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacy
  2. Retail Pharmacy
  3. Online Pharmacy
5. Market Analysis, Insights and Forecast – By Countries/ Sub regions
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Anti-inflammatory Biologics Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Drug Class
  1. Anti-Tumor Necrosis Factor (TNF)
  2. Interleukin Antagonists
  3. Janus Kinase (JAK) Inhibitors
  4. Others
2. Market Analysis, Insights and Forecast – By Application
  1. Rheumatoid Arthritis
  2. Psoriasis
  3. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Injection
    1. Subcutaneous
    2. Intravenous
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacy
  2. Retail Pharmacy
  3. Online Pharmacy
5. Market Analysis, Insights and Forecast – By Countries/ Sub region
  1. South Africa
  2. GCC
  3. Rest of Middle East & Africa
Competitive Analysis
1. Global Market Share Analysis (2021)
2. Company Profiles
  1. AbbVie Inc.
    1. Overview
    2. Products
    3. SWOT analysis
    4. Recent developments
    5. strategies
    6. financials (based on availability)
  2. Johnson & Johnson Services, Inc.
    1. Overview
    2. Products
    3. SWOT analysis
    4. Recent developments
    5. strategies
    6. financials (based on availability)
  3. Bristol-Myers Squibb Company
    1. Overview
    2. Products
    3. SWOT analysis
    4. Recent developments
    5. strategies
    6. financials (based on availability)
  4. Merck & Co., Inc.
    1. Overview
    2. Products
    3. SWOT analysis
    4. Recent developments
    5. strategies
    6. financials (based on availability)
  5. Pfizer Inc.
    1. Overview
    2. Products
    3. SWOT analysis
    4. Recent developments
    5. strategies
    6. financials (based on availability)
  6. Novartis AG
    1. Overview
    2. Products
    3. SWOT analysis
    4. Recent developments
    5. strategies
    6. financials (based on availability)
  7. UCB S.A.
    1. Overview
    2. Products
    3. SWOT analysis
    4. Recent developments
    5. strategies
    6. financials (based on availability)
  8. Eli Lilly and Company
    1. Overview
    2. Products
    3. SWOT analysis
    4. Recent developments
    5. strategies
    6. financials (based on availability)
  9. Amgen Inc.
    1. Overview
    2. Products
    3. SWOT analysis
    4. Recent developments
    5. strategies
    6. financials (based on availability)
  10. Biogen
    1. Overview
    2. Products
    3. SWOT analysis
    4. Recent developments
    5. strategies
    6. financials (based on availability)

Read Less

List of Figures

Figure 1: Global Anti-inflammatory Biologics Market Revenue Breakdown (USD Billion, %) by Region, 2025 & 2034

Figure 2: Global Anti-inflammatory Biologics Market Value Share (%), by Drug Class, 2025 & 2034

Figure 3: Global Anti-inflammatory Biologics Market Forecast (USD Billion), by Anti-Tumor Necrosis Factor (TNF), 2025-2034

Figure 4: Global Anti-inflammatory Biologics Market Forecast (USD Billion), by Interleukin Antagonists, 2025-2034

Figure 5: Global Anti-inflammatory Biologics Market Forecast (USD Billion), by Janus Kinase (JAK) Inhibitors, 2025-2034

Figure 6: Global Anti-inflammatory Biologics Market Forecast (USD Billion), by Others, 2025-2034

Figure 7: Global Anti-inflammatory Biologics Market Value Share (%), by Application, 2025 & 2034

Figure 8: Global Anti-inflammatory Biologics Market Forecast (USD Billion), by Rheumatoid Arthritis, 2025-2034

Figure 9: Global Anti-inflammatory Biologics Market Forecast (USD Billion), by Psoriasis, 2025-2034

Figure 10: Global Anti-inflammatory Biologics Market Forecast (USD Billion), by Others, 2025-2034

Figure 11: Global Anti-inflammatory Biologics Market Value Share (%), by Route of Administration, 2025 & 2034

Figure 12: Global Anti-inflammatory Biologics Market Forecast (USD Billion), by Oral, 2025-2034

Figure 13: Global Anti-inflammatory Biologics Market Forecast (USD Billion), by Injection, 2025-2034

Figure 14: Global Anti-inflammatory Biologics Market Value Share (%), by Distribution Channel, 2025 & 2034

Figure 15: Global Anti-inflammatory Biologics Market Forecast (USD Billion), by Hospital Pharmacy, 2025-2034

Figure 16: Global Anti-inflammatory Biologics Market Forecast (USD Billion), by Retail Pharmacy, 2025-2034

Figure 17: Global Anti-inflammatory Biologics Market Forecast (USD Billion), by Online Pharmacy, 2025-2034

Figure 18: Global Anti-inflammatory Biologics Market Value (USD Billion), by Region, 2025 & 2034

Figure 19: North America Anti-inflammatory Biologics Market Value (USD Billion), by Drug Class, 2025 & 2034

Figure 20: North America Anti-inflammatory Biologics Market Value Share (%), by Drug Class, 2025

Figure 21: North America Anti-inflammatory Biologics Market Value (USD Billion), by Application, 2025 & 2034

Figure 22: North America Anti-inflammatory Biologics Market Value Share (%), by Application, 2025

Figure 23: North America Anti-inflammatory Biologics Market Value (USD Billion), by Route of Administration, 2025 & 2034

Figure 24: North America Anti-inflammatory Biologics Market Value Share (%), by Route of Administration, 2025

Figure 25: North America Anti-inflammatory Biologics Market Value (USD Billion), by Distribution Channel, 2025 & 2034

Figure 26: North America Anti-inflammatory Biologics Market Value Share (%), by Distribution Channel, 2025

Figure 27: North America Anti-inflammatory Biologics Market Value (USD Billion), By Country, 2025 & 2034

Figure 28: North America Anti-inflammatory Biologics Market Value Share (%), By Country, 2025

Figure 29: Europe Anti-inflammatory Biologics Market Value (USD Billion), by Drug Class, 2025 & 2034

Figure 30: Europe Anti-inflammatory Biologics Market Value Share (%), by Drug Class, 2025

Figure 31: Europe Anti-inflammatory Biologics Market Value (USD Billion), by Application, 2025 & 2034

Figure 32: Europe Anti-inflammatory Biologics Market Value Share (%), by Application, 2025

Figure 33: Europe Anti-inflammatory Biologics Market Value (USD Billion), by Route of Administration, 2025 & 2034

Figure 34: Europe Anti-inflammatory Biologics Market Value Share (%), by Route of Administration, 2025

Figure 35: Europe Anti-inflammatory Biologics Market Value (USD Billion), by Distribution Channel, 2025 & 2034

Figure 36: Europe Anti-inflammatory Biologics Market Value Share (%), by Distribution Channel, 2025

Figure 37: Europe Anti-inflammatory Biologics Market Value (USD Billion), By Country/ Sub-region, 2025 & 2034

Figure 38: Europe Anti-inflammatory Biologics Market Value Share (%), By Country/ Sub-region, 2025

Figure 39: Asia Pacific Anti-inflammatory Biologics Market Value (USD Billion), by Drug Class, 2025 & 2034

Figure 40: Asia Pacific Anti-inflammatory Biologics Market Value Share (%), by Drug Class, 2025

Figure 41: Asia Pacific Anti-inflammatory Biologics Market Value (USD Billion), by Application, 2025 & 2034

Figure 42: Asia Pacific Anti-inflammatory Biologics Market Value Share (%), by Application, 2025

Figure 43: Asia Pacific Anti-inflammatory Biologics Market Value (USD Billion), by Route of Administration, 2025 & 2034

Figure 44: Asia Pacific Anti-inflammatory Biologics Market Value Share (%), by Route of Administration, 2025

Figure 45: Asia Pacific Anti-inflammatory Biologics Market Value (USD Billion), by Distribution Channel, 2025 & 2034

Figure 46: Asia Pacific Anti-inflammatory Biologics Market Value Share (%), by Distribution Channel, 2025

Figure 47: Asia Pacific Anti-inflammatory Biologics Market Value (USD Billion), By Country/ Sub-region, 2025 & 2034

Figure 48: Asia Pacific Anti-inflammatory Biologics Market Value Share (%), By Country/ Sub-region, 2025

Figure 49: Latin America Anti-inflammatory Biologics Market Value (USD Billion), by Drug Class, 2025 & 2034

Figure 50: Latin America Anti-inflammatory Biologics Market Value Share (%), by Drug Class, 2025

Figure 51: Latin America Anti-inflammatory Biologics Market Value (USD Billion), by Application, 2025 & 2034

Figure 52: Latin America Anti-inflammatory Biologics Market Value Share (%), by Application, 2025

Figure 53: Latin America Anti-inflammatory Biologics Market Value (USD Billion), by Route of Administration, 2025 & 2034

Figure 54: Latin America Anti-inflammatory Biologics Market Value Share (%), by Route of Administration, 2025

Figure 55: Latin America Anti-inflammatory Biologics Market Value (USD Billion), by Distribution Channel, 2025 & 2034

Figure 56: Latin America Anti-inflammatory Biologics Market Value Share (%), by Distribution Channel, 2025

Figure 57: Latin America Anti-inflammatory Biologics Market Value (USD Billion), By Country/ Sub-region, 2025 & 2034

Figure 58: Latin America Anti-inflammatory Biologics Market Value Share (%), By Country/ Sub-region, 2025

Figure 59: Middle East & Africa Anti-inflammatory Biologics Market Value (USD Billion), by Drug Class, 2025 & 2034

Figure 60: Middle East & Africa Anti-inflammatory Biologics Market Value Share (%), by Drug Class, 2025

Figure 61: Middle East & Africa Anti-inflammatory Biologics Market Value (USD Billion), by Application, 2025 & 2034

Figure 62: Middle East & Africa Anti-inflammatory Biologics Market Value Share (%), by Application, 2025

Figure 63: Middle East & Africa Anti-inflammatory Biologics Market Value (USD Billion), by Route of Administration, 2025 & 2034

Figure 64: Middle East & Africa Anti-inflammatory Biologics Market Value Share (%), by Route of Administration, 2025

Figure 65: Middle East & Africa Anti-inflammatory Biologics Market Value (USD Billion), by Distribution Channel, 2025 & 2034

Figure 66: Middle East & Africa Anti-inflammatory Biologics Market Value Share (%), by Distribution Channel, 2025

Figure 67: Middle East & Africa Anti-inflammatory Biologics Market Value (USD Billion), By Country/ Sub-region, 2025 & 2034

Figure 68: Middle East & Africa Anti-inflammatory Biologics Market Value Share (%), By Country/ Sub-region, 2025

Figure 69: Global Anti-inflammatory Biologics Market Share (%), By Company, 2025

List of Tables

Table 1: Global Anti-inflammatory Biologics Market Revenue (USD Billion) Forecast, by Drug Class, 2021–2034

Table 2: Global Anti-inflammatory Biologics Market Revenue (USD Billion) Forecast, by Application, 2021–2034

Table 3: Global Anti-inflammatory Biologics Market Revenue (USD Billion) Forecast, by Route of Administration, 2021–2034

Table 4: Global Anti-inflammatory Biologics Market Revenue (USD Billion) Forecast, by Injection, 2021–2034

Table 5: Global Anti-inflammatory Biologics Market Revenue (USD Billion) Forecast, by Distribution Channel, 2021–2034

Table 6: Global Anti-inflammatory Biologics Market Revenue (USD Billion) Forecast, by Region, 2021-2034

Table 7: North America Anti-inflammatory Biologics Market Revenue (USD Billion) Forecast, by Drug Class, 2021-2034

Table 8: North America Anti-inflammatory Biologics Market Revenue (USD Billion) Forecast, by Application, 2021-2034

Table 9: North America Anti-inflammatory Biologics Market Revenue (USD Billion) Forecast, by Route of Administration, 2021-2034

Table 10: North America Anti-inflammatory Biologics Market Revenue (USD Billion) Forecast, by Injection, 2021–2034

Table 11: North America Anti-inflammatory Biologics Market Revenue (USD Billion) Forecast, by Distribution Channel, 2021-2034

Table 12: North America Anti-inflammatory Biologics Market Revenue (USD Billion) Forecast, By Country, 2021-2034

Table 13: Europe Anti-inflammatory Biologics Market Revenue (USD Billion) Forecast, by Drug Class, 2021-2034

Table 14: Europe Anti-inflammatory Biologics Market Revenue (USD Billion) Forecast, by Application, 2021-2034

Table 15: Europe Anti-inflammatory Biologics Market Revenue (USD Billion) Forecast, by Route of Administration, 2021-2034

Table 16: Europe Anti-inflammatory Biologics Market Revenue (USD Billion) Forecast, by Injection, 2021–2034

Table 17: Europe Anti-inflammatory Biologics Market Revenue (USD Billion) Forecast, by Distribution Channel, 2021-2034

Table 18: Europe Anti-inflammatory Biologics Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2021-2034

Table 19: Asia Pacific Anti-inflammatory Biologics Market Revenue (USD Billion) Forecast, by Drug Class, 2021-2034

Table 20: Asia Pacific Anti-inflammatory Biologics Market Revenue (USD Billion) Forecast, by Application, 2021-2034

Table 21: Asia Pacific Anti-inflammatory Biologics Market Revenue (USD Billion) Forecast, by Route of Administration, 2021-2034

Table 22: Asia Pacific Anti-inflammatory Biologics Market Revenue (USD Billion) Forecast, by Injection, 2021–2034

Table 23: Asia Pacific Anti-inflammatory Biologics Market Revenue (USD Billion) Forecast, by Distribution Channel, 2021-2034

Table 24: Asia Pacific Anti-inflammatory Biologics Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2021-2034

Table 25: Latin America Anti-inflammatory Biologics Market Revenue (USD Billion) Forecast, by Drug Class, 2021-2034

Table 26: Latin America Anti-inflammatory Biologics Market Revenue (USD Billion) Forecast, by Application, 2021-2034

Table 27: Latin America Anti-inflammatory Biologics Market Revenue (USD Billion) Forecast, by Route of Administration, 2021-2034

Table 28: Latin America Anti-inflammatory Biologics Market Revenue (USD Billion) Forecast, by Injection, 2021–2034

Table 29: Latin America Anti-inflammatory Biologics Market Revenue (USD Billion) Forecast, by Distribution Channel, 2021-2034

Table 30: Latin America Anti-inflammatory Biologics Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2021-2034

Table 31: Middle East & Africa Anti-inflammatory Biologics Market Revenue (USD Billion) Forecast, by Drug Class, 2021-2034

Table 32: Middle East & Africa Anti-inflammatory Biologics Market Revenue (USD Billion) Forecast, by Application, 2021-2034

Table 33: Middle East & Africa Anti-inflammatory Biologics Market Revenue (USD Billion) Forecast, by Route of Administration, 2021-2034

Table 34: Middle East & Africa Anti-inflammatory Biologics Market Revenue (USD Billion) Forecast, by Injection, 2021–2034

Table 35: Middle East & Africa Anti-inflammatory Biologics Market Revenue (USD Billion) Forecast, by Distribution Channel, 2021-2034

Table 36: Middle East & Africa Anti-inflammatory Biologics Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2021-2034

STUDY PERIOD: 2021-2034
BASE YEAR: 2025
HISTORICAL DATA: 2021-2024
NO OF PAGES: 145

Buy Now

Download Free Sample

Security Code

Get 20% Free Customization

Expand Regional and Country Coverage, Segments Analysis, Company Profiles, Competitive Benchmarking, and End-user Insights.

Growth Advisory Services

Clients

Related Reports

Get In Touch With Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

(APAC) +91 744 740 1245
sales@fortunebusinessinsights.com